Home › Funds › Nippon Life Global Investors Americas, Inc. › CVS
Nippon Life Global Investors Americas, Inc. position in CVS
CVS HEALTH CORP · Consumer Staples
Nippon Life Global Investors Americas, Inc. reported holding 367,540 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$31.5M, representing 1.26% of its reported portfolio and ranking #26 among its reported holdings. Nippon Life Global Investors Americas, Inc. has disclosed CVS holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Nippon Life Global Investors Americas, Inc.'s CVS position evolved
Nippon Life Global Investors Americas, Inc. first disclosed a stake in CVS in Q3 2023 at 26,740 shares (US$1.9M). The position peaked in Q2 2026 at 347,480 shares, worth US$35.9M. Across 7 filings, Nippon Life Global Investors Americas, Inc. increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 367,540 shares valued at US$31.5M — an increase of 20,060 shares quarter over quarter.. Notable position changes include a 265% increase in Q1 2026 (shares rose 45% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 26.74K | $1.87M | New |
| Q2 2025 | 72.60K | $5.01M | New |
| Q3 2025 | 89.25K | $6.73M | Add |
| Q4 2025 | 101.55K | $8.06M | Add |
| Q1 2026 | 370.23K | $26.59M | Add |
| Q2 2026 | 347.48K | $35.95M | Reduce |
| Q3 2026 | 367.54K | $31.49M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.90M sh · $1.02B · Q3 2026
- Pzena Investment Management 10.30M sh · $882.34M · Q3 2026
More on Nippon Life Global Investors Americas, Inc.
FAQ
How long has Nippon Life Global Investors Americas, Inc. held CVS?
Nippon Life Global Investors Americas, Inc. has disclosed CVS holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is Nippon Life Global Investors Americas, Inc.'s current position in CVS?
As of Q3 2026, Nippon Life Global Investors Americas, Inc. holds 367.54K shares of CVS (CVS HEALTH CORP), valued at $31.49M, representing 1.26% of its reported portfolio and ranking #26.
Has Nippon Life Global Investors Americas, Inc. been buying or selling CVS?
In the latest 13F filing (Q3 2026), Nippon Life Global Investors Americas, Inc. increased its position in CVS. The position peaked in Q2 2026 at 347.48K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.